Abstract:The therapeutic outcome of chemodynamic therapy (CDT) is greatly hindered by the presence of oxidative damage repair proteins (MTH1) inside the cancer cell. These oxidative damage repair proteins detoxify the action of radicals generated by Fenton or Fenton-like reactions. Hence, it is extremely important to develop a simple strategy for the downregulation of MTH1 protein inside the cancer cell along with the delivery of metal ions into cancer cells. A one-pot host-guest supramolecular approach for the codelivery of MTH1 siRNA and metal ions into the cancer cell is reported. Our approach involves the fabrication of an inclusion complex between cationic β-cyclodextrin and ferrocene prodrug to form an inclusion complex between β-cyclodextrin and the prodrug, which spontaneously undergoes amphiphilicity-driven self-assembly to form spherical nanoparticle (NPs) having positively charged surface. The cationic surface of the NPs was then explored for the loading of MTH1 siRNA through electrostatic interactions. Using HeLa cells as the representative example, efficient uptake of the NPs, delivery of MTH1 siRNA and the enhanced CDT of the nanoformulation are demonstrated. This work highlights the potential of the supramolecular approach as a simple yet efficient tool for the delivery of siRNA across the cell membrane for enhanced chemodynamic therapy.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the therapeutic effect of chemodynamic therapy (CDT) on cancer cells. Specifically, the authors focus on how to overcome the obstruction of the CDT efficacy by the oxidative damage repair proteins (such as MTH1 protein) existing in cancer cells. ### Main problems: 1. **Existence of MTH1 protein**: The MTH1 protein can repair the oxidative damage caused by reactive oxygen species (ROS), thus protecting cancer cells from the killing effect of CDT. This greatly reduces the efficacy of CDT. 2. **Delivery of metal ions and siRNA**: In order to enhance the effect of CDT, a simple and effective method is required to simultaneously deliver MTH1 siRNA (used to down - regulate the expression of MTH1 protein) and metal ions (used to catalyze the Fenton reaction to generate ROS) into cancer cells. ### Solutions: The authors propose a supramolecular self - assembly - based strategy, which is achieved through the following steps: 1. **Construction of a nano - platform**: Utilize the host - guest interaction between cationic β - cyclodextrin (β - CD+) and ferrocene prodrug to form an inclusion complex, and further self - assemble into positively charged spherical nanoparticles (β - CD+/1 NPs). 2. **Loading of siRNA**: Since the surfaces of these nanoparticles are positively charged, they can efficiently load MTH1 siRNA through electrostatic interaction to form β - CD+/1/siRNA NPs. 3. **Cell uptake and intracellular release**: After entering cancer cells through the endocytic pathway, the nanoparticles can escape from lysosomes and disperse in the cytoplasm, release siRNA to inhibit the expression of MTH1 protein, while the ferrocene prodrug reacts with intracellular hydrogen peroxide (H₂O₂) to generate highly toxic hydroxyl radicals (•OH) and consume glutathione (GSH), thereby significantly enhancing the effect of CDT. ### Summary: This study aims to develop a simple and effective co - delivery system. By simultaneously delivering MTH1 siRNA and Fenton reagents, it overcomes the resistance of MTH1 protein in cancer cells to CDT, thereby significantly improving the efficacy of CDT.

Multifunctional siRNA/ferrocene/cyclodextrin nanoparticles for enhanced chemodynamic cancer therapy

Tumor-targeted supramolecular catalytic nanoreactor for synergistic chemo/chemodynamic therapy via oxidative stress amplification and cascaded Fenton reaction

Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy

Boosting Chemodynamic Therapy by Tumor-Targeting and Cellular Redox Homeostasis-Disrupting Nanoparticles.

Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers

Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy

Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity

Manganese Self-boosting Hollow Nanoenzymes with Glutathione Depletion for Synergistic Cancer Chemo-chemodynamic Therapy

Bimetallic DNAsome Decorated with G4‐DNA as a Nanozyme for Targeted and Enhanced Chemo/Chemodynamic Cancer Therapy

Tumor-targeted delivery of hyaluronic acid/polydopamine-coated Fe2+-doped nano-scaled metal-organic frameworks with doxorubicin payload for glutathione depletion-amplified chemodynamic-chemo cancer therapy

Supramolecular Polymerization‐Induced Nanoassemblies for Self‐Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor

A Hybrid Supramolecular Polymeric Nanomedicine for Cascade-Amplified Synergetic Cancer Therapy.

Active-transporting of charge-reversal Cu(II)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy

A versatile supramolecular nanoagent for three-pronged boosting chemodynamic therapy

A Supramolecular Co-Delivery Strategy for Combined Breast Cancer Treatment and Metastasis Prevention

A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects

Conjugated Polymer-Ferrocence Nanoparticle As an NIR-II Light Powered Nanoamplifier to Enhance Chemodynamic Therapy

Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy

Multifunctional Fe-based coordination polymer nano-bomb modified with β-lapachone and CaO2 for targeted tumor dual chemodynamic therapy with enhanced ferroptosis and H2O2 self-supply

Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy

Smart Responsive Nanoplatform Via in Situ Forming Disulfiram-Copper Ion Chelation Complex for Cancer Combination Chemotherapy